miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy

SIMPLE SUMMARY: Cancer onset and progression are promoted by high deregulation of the immune system. Recently, major advances in molecular and clinical cancer immunology have been achieved, offering new agents for the treatment of common tumors, often with astonishing benefits in terms of prolonged...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Martino, Maria Teresa, Riillo, Caterina, Scionti, Francesca, Grillone, Katia, Polerà, Nicoletta, Caracciolo, Daniele, Arbitrio, Mariamena, Tagliaferri, Pierosandro, Tassone, Pierfrancesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036682/
https://www.ncbi.nlm.nih.gov/pubmed/33808190
http://dx.doi.org/10.3390/cancers13071587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036682/
https://www.ncbi.nlm.nih.gov/pubmed/33808190
http://dx.doi.org/10.3390/cancers13071587

Ejemplares similares